Posted Oct 27, 2022, 4:44 PM
Satelia is a UFO in the start-up landscape. This Bordeaux medtech specializing in remote monitoring of patients with chronic diseases is already profitable, even though it was only founded five years ago. A performance notably enabled by obtaining the precious sesame allowing a 100% reimbursement by social security of its solution. If the beginnings are therefore very promising in France, with its platform already available in 220 French care centers, its founder, Nicolas Pages, an anesthesiologist-resuscitator, wants to see bigger. The company, which was self-financing until then, has just raised an envelope of €10 million, notably matched by Impact Partners for the equity part – which is the majority. A small debt completes this financing.
10,000 patients followed
